Christopher Richard Anzalone Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

Christopher Richard Anzalone is Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 4.06 Million shares of ARWR, which is worth approximately $60.1 Million. The most recent transaction as insider was on Mar 13, 2025, when has been sold 51,425 shares (Common Stock) at a price of $15.07 per share, resulting in proceeds of $774,974. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.06M

7.59% 3M change

9.35% 12M change

Total Value Held $60.1 Million

Christopher Richard Anzalone Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 13 2025	SELL Open market or private sale	$774,974 $15.07 p/Share	51,425 Reduced 1.25%	4,062,377 Common Stock
Mar 13 2025	BUY Grant, award, or other acquisition	-	340,000 Added 7.63%	4,113,802 Common Stock
Mar 04 2025	SELL Open market or private sale	$2,269,327 $17.02 p/Share	133,333 Reduced 3.41%	3,773,802 Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	$1,033,330 $7.75 p/Share	133,333 Added 3.17%	4,073,802 Common Stock
Mar 03 2025	SELL Open market or private sale	$3,005,006 $18.03 p/Share	166,667 Reduced 4.09%	3,907,135 Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	$1,291,669 $7.75 p/Share	166,667 Added 4.06%	3,940,469 Common Stock
Feb 07 2025	BUY Grant, award, or other acquisition	$191,955 $20.1 p/Share	9,550 Added 0.25%	3,773,802 Common Stock
Jan 02 2025	SELL Open market or private sale	$219,456 $19.05 p/Share	11,520 Reduced 0.31%	3,764,252 Common Stock
Dec 23 2024	SELL Open market or private sale	$246,109 $19.59 p/Share	12,563 Reduced 0.33%	3,775,772 Common Stock
Dec 18 2024	SELL Open market or private sale	$573,239 $21.46 p/Share	26,712 Reduced 0.72%	3,688,335 Common Stock
Dec 18 2024	BUY Grant, award, or other acquisition	-	100,000 Added 2.57%	3,788,335 Common Stock
Jan 31 2024	SELL Open market or private sale	$1,864,692 $32.43 p/Share	57,499 Reduced 1.52%	3,715,048 Common Stock
Jan 31 2024	BUY Exercise of conversion of derivative security	$836,035 $14.54 p/Share	57,499 Added 1.5%	3,772,547 Common Stock
Jan 02 2024	SELL Open market or private sale	$308,512 $31.0 p/Share	9,952 Reduced 0.27%	3,715,048 Common Stock
Dec 20 2023	SELL Open market or private sale	$342,480 $28.54 p/Share	12,000 Reduced 0.32%	3,725,000 Common Stock
Oct 25 2023	SELL Open market or private sale	$589,222 $24.21 p/Share	24,338 Reduced 0.65%	3,737,000 Common Stock
Sep 18 2023	SELL Open market or private sale	$1,625,225 $28.14 p/Share	57,755 Reduced 1.51%	3,761,338 Common Stock
Sep 18 2023	BUY Exercise of conversion of derivative security	$274,336 $4.75 p/Share	57,755 Added 1.49%	3,819,093 Common Stock
May 04 2023	SELL Open market or private sale	$1,975,000 $39.5 p/Share	50,000 Reduced 1.31%	3,761,338 Common Stock
May 04 2023	BUY Exercise of conversion of derivative security	$100,499 $2.01 p/Share	50,000 Added 1.29%	3,811,338 Common Stock
May 03 2023	SELL Open market or private sale	$2,149,881 $39.14 p/Share	54,928 Reduced 1.44%	3,761,338 Common Stock
May 03 2023	BUY Exercise of conversion of derivative security	$110,405 $2.01 p/Share	54,928 Added 1.42%	3,816,266 Common Stock
Dec 20 2022	BUY Grant, award, or other acquisition	-	234,025 Added 5.92%	3,720,714 Common Stock
Dec 16 2022	BUY Grant, award, or other acquisition	-	18,375 Added 0.52%	3,486,689 Common Stock
Sep 27 2022	SELL Exercise of conversion of derivative security	$1,258,938 $30.99 p/Share	40,624 Reduced 1.16%	3,468,314 Common Stock

CRA

Christopher Richard Anzalone

Chief Executive Officer

Pasadena, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Value

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

Operation

Value

Type

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Track Activities on ARWR

Account